Effectiveness of the First Dose of BCG against Tuberculosis among HIV-Infected, Predominantly Immunodeficient Children

Table 3

Odds ratios of the association between BCG vaccination and TB adjusted for biological, family structure, healthcare, and socioeconomic variables and clinical conditions. Hospital Pediátrico David Bernardino (HPDB, Angola): January 2005–December 2006.

Variables		95% CI	value
BCG (adjusted for biological variables	0.88	0.64 to 1.21	0.42
BCG (adjusted for family structure variables	0.85	0.57 to 1.26	0.41
BCG (adjusted for healthcare variables	0.79	0.40 to 1.56	0.50
BCG (adjusted for socioeconomic variables	0.91	0.66 to 1.27	0.59
BCG (adjusted for clinical condition variables	1.14	0.78 to 1.65	0.49

BCG: Bacille Calmette-Guérin; TB: tuberculosis; OR: odds ratio; CI: confidence interval; age; age, orphaned, and sibling died of AIDS; age, admission point, adherence to antiretroviral treatment, distance to health center, and regularity of AIDS consultations; age, employment status, number of people living in household, and housing conditions; age, previous history of pneumonia, clinical category of HIV infection (CDC), and degree of immunodeficiency.